Which of the following statements by the nurse is appropriate when reviewing a client's rubella titer of 1:8 at her second prenatal visit?

Choice A reason: Stating that rubella vaccination prevents breastfeeding is incorrect. The rubella vaccine, a live-attenuated virus, is safe for postpartum administration in non-immune mothers, as it does not significantly excrete in breast milk or harm the infant. Breastfeeding supports neonatal immunity through maternal antibodies, and this statement misrepresents vaccine safety and breastfeeding physiology. Choice B reason: Repeating a rubella titer in the third trimester is unnecessary unless new exposure is suspected. A titer of 1:8 indicates susceptibility, requiring postpartum immunization, not repeated testing. Serological testing monitors antibody levels, but rubella immunity status typically remains stable during pregnancy unless infection occurs, making routine retesting scientifically unjustified in this context. Choice C reason: Administering rubella immunization during pregnancy is contraindicated, as it is a live vaccine that poses a theoretical risk to the fetus. A titer of 1:8 indicates susceptibility, warranting postpartum vaccination. The immune system’s response to live vaccines could potentially cross the placenta, affecting fetal development, so immunization is deferred until after delivery. Choice D reason: A rubella titer of 1:8 indicates susceptibility, as titers below 1:10 suggest insufficient antibodies to confer immunity. Rubella infection during pregnancy can cause congenital rubella syndrome, leading to fetal anomalies. This statement accurately reflects the need for postpartum immunization to protect future pregnancies, aligning with serological evidence and prenatal care guidelines.